Ariel Investments, LLC Charles River Laboratories International, Inc. Transaction History

Ariel Investments, LLC

  • $8.16 Billion
  • Q3 2025

A detailed history of Ariel Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ariel Investments, LLC holds 1,490,098 shares of CRL stock, worth $250 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
1,490,098
Previous 1,415,348 5.28%
Holding current value
$250 Million
Previous $215 Million 8.56%
% of portfolio
2.86%
Previous 2.73%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$145.57 - $178.99 $10.9 Million - $13.4 Million
74,750 Added 5.28%
1,490,098 $233 Million
Q2 2025

Aug 14, 2025
BUY
$99.75 - $151.89 $31.4 Million - $47.8 Million
314,572 Added 28.58%
1,415,348 $215 Million
Q1 2025

May 15, 2025
BUY
$150.52 - $190.14 $5.03 Million - $6.36 Million
33,449 Added 3.13%
1,100,776 $166 Million
Q4 2024

Feb 13, 2025
BUY
$178.58 - $220.69 $30.3 Million - $37.4 Million
169,640 Added 18.9%
1,067,327 $197 Million
Q3 2024

Nov 13, 2024
SELL
$187.96 - $245.29 $1.59 Million - $2.07 Million
-8,450 Reduced 0.93%
897,687 $177 Million
Q2 2024

Aug 14, 2024
SELL
$206.39 - $268.73 $5.5 Million - $7.17 Million
-26,670 Reduced 2.86%
906,137 $187 Million
Q1 2024

May 14, 2024
SELL
$203.52 - $273.43 $24 Million - $32.2 Million
-117,891 Reduced 11.22%
932,807 $253 Million
Q4 2023

Feb 14, 2024
SELL
$164.52 - $238.84 $2.62 Million - $3.8 Million
-15,902 Reduced 1.49%
1,050,698 $248 Million
Q3 2023

Nov 14, 2023
BUY
$194.44 - $217.61 $3.65 Million - $4.08 Million
18,760 Added 1.79%
1,066,600 $209 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $67 Million - $76.7 Million
364,786 Added 53.41%
1,047,840 $220 Million
Q1 2023

May 12, 2023
BUY
$191.89 - $259.92 $8.69 Million - $11.8 Million
45,292 Added 7.1%
683,054 $138 Million
Q4 2022

Feb 14, 2023
SELL
$197.11 - $250.07 $2.51 Million - $3.18 Million
-12,736 Reduced 1.96%
637,762 $139 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $11.1 Million - $15.2 Million
60,859 Added 10.32%
650,498 $128 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $77.5 Million - $115 Million
379,844 Added 181.05%
589,639 $126 Million
Q1 2022

May 13, 2022
BUY
$255.51 - $362.11 $7.7 Million - $10.9 Million
30,148 Added 16.78%
209,795 $59.6 Million
Q4 2021

Feb 14, 2022
SELL
$351.38 - $448.68 $1.25 Million - $1.6 Million
-3,558 Reduced 1.94%
179,647 $67.7 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $14.1 Million - $17.4 Million
-37,894 Reduced 17.14%
183,205 $75.6 Million
Q2 2021

Aug 13, 2021
SELL
$294.17 - $371.65 $55.9 Million - $70.6 Million
-189,974 Reduced 46.21%
221,099 $81.8 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $447,658 - $536,967
-1,793 Reduced 0.43%
411,073 $119 Million
Q4 2020

Feb 12, 2021
SELL
$222.0 - $252.62 $17.2 Million - $19.6 Million
-77,476 Reduced 15.8%
412,866 $103 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $23.6 Million - $30.4 Million
-134,264 Reduced 21.5%
490,342 $111 Million
Q2 2020

Aug 14, 2020
SELL
$118.84 - $189.72 $7.25 Million - $11.6 Million
-60,977 Reduced 8.89%
624,606 $109 Million
Q1 2020

May 14, 2020
SELL
$98.9 - $178.34 $16.3 Million - $29.3 Million
-164,511 Reduced 19.35%
685,583 $86.5 Million
Q4 2019

Feb 14, 2020
BUY
$126.05 - $152.76 $1.07 Million - $1.3 Million
8,497 Added 1.01%
850,094 $130 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $3.26 Million - $3.75 Million
26,090 Added 3.2%
841,597 $111 Million
Q2 2019

Aug 14, 2019
SELL
$123.4 - $148.55 $3.82 Million - $4.6 Million
-30,935 Reduced 3.65%
815,507 $116 Million
Q1 2019

May 15, 2019
SELL
$104.82 - $146.73 $14.9 Million - $20.8 Million
-141,729 Reduced 14.34%
846,442 $123 Million
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $27.9 Million - $36.5 Million
-265,795 Reduced 21.2%
988,171 $112 Million
Q3 2018

Nov 14, 2018
SELL
$112.11 - $134.54 $7.13 Million - $8.56 Million
-63,620 Reduced 4.83%
1,253,966 $169 Million
Q2 2018

Aug 10, 2018
SELL
$102.37 - $117.25 $4.47 Million - $5.12 Million
-43,691 Reduced 3.21%
1,317,586 $148 Million
Q1 2018

May 14, 2018
BUY
$98.19 - $115.2 $793,571 - $931,046
8,082 Added 0.6%
1,361,277 $145 Million
Q4 2017

Feb 14, 2018
SELL
$100.43 - $118.09 $32.8 Million - $38.6 Million
-326,871 Reduced 19.46%
1,353,195 $148 Million
Q3 2017

Nov 14, 2017
SELL
$96.72 - $109.26 $26.1 Million - $29.5 Million
-270,301 Reduced 13.86%
1,680,066 $181 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,950,367
1,950,367 $197 Million

Others Institutions Holding CRL

# of Institutions
642
Shares Held
51.6M
Call Options Held
194K
Put Options Held
174K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ariel Investments, LLC Portfolio

Follow Ariel Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ariel Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email